Preventive and Emergency Maintenance and Support Services for One (1) Government-owned Bruker Avance Neo 700 NMR Spectrometer 75N91025Q00042

The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Urologic Oncology Branch (UOB), plans to procure, on a sole source basis, all labor, material, parts and equipment necessary to maintain one (1) Bruker Avance Neo 700 NMR spectrometer, Serial Number 10280140, to include coverage of the following configured items: - - NMR console, - NMR cryoplatform, - NMR probe, - NMR cooled samplejet, and NMR bay control unit (BCU). Bruker Biospin Corp. 15 Fortune Dr. Billerica, MA 01821-3923, USA UEID: WWMWFMKJLH33 The response close date of the notice for this requirement is in accordance with FAR 5.203(b). This acquisition will be processed under FAR Part 12 – Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.106-1 (b)(1) and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 811210 and the business size standard is $34.0 million. The Metabolomic Core at the Urologic Oncology Branch, National Cancer Institute, National Institutes of Health (NIH), utilizes a Bruker Avance Neo 700 nuclear magnetic resonance NMR spectrometer on a daily basis for clinical and research metabolomics applications. This NMR spectrometer is crucial for the metabolic analysis of cultured cells and of biosamples from NIH clinical patients undergoing intraoperative infusion of stable isotope tracers. The equipment cannot be out of service for a prolonged time without causing severe delays to a significant number of clinical and research efforts across the branch. Bruker Biospin Corp. is the OEM, and the sole provider of preventive maintenance service, emergency service, proprietary software and software upgrades, replacement part installation, and OEM-authorized and trained technical service personnel for real-time troubleshooting and diagnosing issues that arise during regular operation of the instrument. Bruker Biospin Corp. does not authorize any other entity to perform any of the required services on the Bruker Avance Neo 700 nuclear magnetic resonance NMR spectrometer. Therefore, Bruker Biospin Corp is the only source capable of meeting the Government’s needs. This notice is not a request for competitive quotations. However, if any interested party, especially a small business, believes it can meet the Government’s needs, it may submit a capability statement, proposal, or quote for the Government to consider. The response and any other information furnished must be in writing and must contain sufficient details to allow NCI to determine if the party can perform the requirement. Responses to this notice shall be submitted via email to Contract Specialist, David Romley at David.Romley@nih.gov no later than 12:00 P.M. EST on Tuesday, July 8, 2025 (7/8/2025). A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered for the purpose of determining whether to conduct a competitive procurement. The Government reserves the right to use the information provided by respondents for any purpose deemed necessary and legally appropriate. To receive an award, Contractors must be registered and have valid certification through SAM.GOV. Please reference the notice number 75N91025Q00042 on all correspondence. ***Please reference attached Statement of Work for more details pertaining to the nature of the work to be performed.***